<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Ophthalmology</title>
            <link>https://medicalxpress.com/ophthalmology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Ophthalmology</description>

                            <item>
                    <title>Lab-grown aging eye model reveals early AMD markers in weeks</title>
                    <description>The rods and cones in your eyes are responsible for helping you see, but what is responsible for helping them? Retinal pigment epithelium cells are their caretakers, but environmental, genetic and aging factors can strain them and make them less effective. This is known as age-related macular degeneration—a leading cause of blindness.</description>
                    <link>https://medicalxpress.com/news/2026-06-lab-grown-aging-eye-reveals.html</link>
                    <category></category>
                    <pubDate>Sun, 07 Jun 2026 06:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news700029566</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-new-vision-how-utah.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New AI tools could help eye doctors diagnose retinal disease faster</title>
                    <description>Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye&#039;s surface without causing discomfort or pain to the patient. Used routinely in clinics worldwide, the scans produce detailed views of individual layers of the eye&#039;s interior to help diagnose conditions that threaten vision. But with that level of precision comes a flood of data—hundreds of images per scan that physicians have to review manually, a time-consuming process that is vulnerable to human error.</description>
                    <link>https://medicalxpress.com/news/2026-06-ai-tools-eye-doctors-retinal.html</link>
                    <category></category>
                    <pubDate>Fri, 05 Jun 2026 18:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news699881657</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-ai-tools-could-hel.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood proteins may flag diabetic retinal degeneration before symptoms appear</title>
                    <description>An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic patients before symptoms occur, according to a study published in PLOS Medicine by Huangdong Li from the Guangdong Provincial Clinical Research Center for Ocular Diseases in Guangzhou, China, and colleagues.</description>
                    <link>https://medicalxpress.com/news/2026-06-blood-proteins-flag-diabetic-retinal.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 14:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news699546421</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/proteins-in-blood-coul.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study identifies protein that helps eye cancer spread to the liver</title>
                    <description>A study led by researchers at Moffitt Cancer Center helps explain why uveal melanoma, the most common form of eye cancer, often spreads to the liver. The uvea is the middle layer of the eye, including the iris.</description>
                    <link>https://medicalxpress.com/news/2026-05-protein-eye-cancer-liver.html</link>
                    <category></category>
                    <pubDate>Fri, 29 May 2026 08:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news699262322</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/iris.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New genetic map of the human eye reveals clues to vision loss</title>
                    <description>An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help explain why millions of people develop sight-threatening conditions such as age-related macular degeneration (AMD), as well as rarer inherited eye diseases. The research is published in Nature Communications.</description>
                    <link>https://medicalxpress.com/news/2026-05-genetic-human-eye-reveals-clues.html</link>
                    <category></category>
                    <pubDate>Tue, 26 May 2026 08:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news699001502</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/eye-iris.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Atopic dermatitis linked to increased risk for retinal detachment</title>
                    <description>A history of atopic dermatitis (AD) is associated with an increased risk for retinal detachment (RD), according to a study published in Ophthalmology Retina.</description>
                    <link>https://medicalxpress.com/news/2026-05-atopic-dermatitis-linked-retinal-detachment.html</link>
                    <category></category>
                    <pubDate>Mon, 25 May 2026 21:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news698914501</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/atopic-dermatitis-link-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New study could improve testing and treatment for rare brain, spinal cord, and eye cancers</title>
                    <description>A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.</description>
                    <link>https://medicalxpress.com/news/2026-05-treatment-rare-brain-spinal-cord.html</link>
                    <category></category>
                    <pubDate>Fri, 22 May 2026 19:40:02 EDT</pubDate>
                    <guid isPermaLink="false">news698677286</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/oncologist.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Eye drop formulation can treat dry eye disease</title>
                    <description>Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease. The team reports in Investigative Ophthalmology &amp; Visual Science that the treatment significantly reduced typical dry eye characteristics, such as inflammation, damage to the eye surface and loss of goblet cells, which produce factors that help stabilize tears and lubricate the eye. The findings support conducting human studies to assess the safety and efficacy of this treatment that could potentially benefit millions of people with dry eye disease.</description>
                    <link>https://medicalxpress.com/news/2026-05-eye-dry-disease.html</link>
                    <category></category>
                    <pubDate>Thu, 21 May 2026 10:20:02 EDT</pubDate>
                    <guid isPermaLink="false">news698576762</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/eyedrop.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How looking through static can help people with a common degenerative disease see better</title>
                    <description>Age-related macular degeneration (AMD) is the leading cause of irreversible blindness among aging people globally. Around one in seven Australians over the age of 50 have some signs of AMD.</description>
                    <link>https://medicalxpress.com/news/2026-05-static-people-common-degenerative-disease.html</link>
                    <category></category>
                    <pubDate>Mon, 18 May 2026 14:20:09 EDT</pubDate>
                    <guid isPermaLink="false">news698332117</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-looking-through-st.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Written in the eye: How the retina&#039;s biological age could help predict osteoporosis risk</title>
                    <description>Eyes, the high-resolution biological devices that help us visualize the outside world, are now being used as a portal to assess our internal health. Scientists have found that a closer evaluation of how one&#039;s retina is aging can provide crucial hints about bone health, especially in conditions such as osteoporosis, which makes bones weaker and more prone to fractures.</description>
                    <link>https://medicalxpress.com/news/2026-05-written-eye-retina-biological-age.html</link>
                    <category></category>
                    <pubDate>Mon, 18 May 2026 12:00:09 EDT</pubDate>
                    <guid isPermaLink="false">news698322087</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/written-in-the-eye-sci-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Project expands access to care for children with amblyopia</title>
                    <description>A group of pediatric eye disease researchers has launched an open-access tool designed to help manage pediatric cases of amblyopia, a condition in which the brain fails to properly develop normal vision in one or both eyes early in life. It is the leading cause of preventable single-eye (monocular) vision loss, affecting 3 of every 100 children in the nation. The tool is aimed at expanding access to evidence-based amblyopia clinical-decision-making expertise amidst a shortage of pediatric eye care specialists in the United States.</description>
                    <link>https://medicalxpress.com/news/2026-05-access-children-amblyopia.html</link>
                    <category></category>
                    <pubDate>Mon, 18 May 2026 10:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news698317801</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/child-with-glasses-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Depressed mice successfully treated with smart contact lenses that zap their brains: New study</title>
                    <description>Scientists in South Korea have developed experimental contact lenses designed to send electrical signals through the retina and into brain regions linked to mood. In mice, the technology appeared to improve depression-like behavior.</description>
                    <link>https://medicalxpress.com/news/2026-05-depressed-mice-successfully-smart-contact.html</link>
                    <category></category>
                    <pubDate>Thu, 14 May 2026 13:44:17 EDT</pubDate>
                    <guid isPermaLink="false">news697984922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/mice.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Contact lenses treat depression in mice as effectively as anti-depressant medication</title>
                    <description>Materials scientists have designed brain-stimulating contact lenses that are as effective as Prozac at treating depression in mice. The soft, transparent contact lenses have in-built electrodes that deliver mild electrical signals to the brain via the retina to stimulate specific brain regions associated with depression.</description>
                    <link>https://medicalxpress.com/news/2026-05-contact-lenses-depression-mice-effectively.html</link>
                    <category></category>
                    <pubDate>Thu, 14 May 2026 11:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news697885681</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/contactlens.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New findings provide clues for severe age-related macular degeneration</title>
                    <description>Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related macular degeneration (AMD). Their findings, published in Genome Medicine, could help inform future efforts to develop more targeted treatments for people at greatest risk of developing severe macular degeneration and losing their sight.</description>
                    <link>https://medicalxpress.com/news/2026-05-clues-severe-age-macular-degeneration.html</link>
                    <category></category>
                    <pubDate>Tue, 12 May 2026 09:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news697794421</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/eyes-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Genome-wide screen yields new gene therapies to protect against retinal degeneration</title>
                    <description>Researchers in the WashU Medicine Department of Ophthalmology &amp; Visual Sciences have discovered key neuroprotective genes that could lead to the development of gene therapies to treat retinitis pigmentosa, an inherited form of retinal degeneration that causes blindness. The findings, published in Neuron, point to new therapeutic strategies to maintain retinal health and protect against degeneration.</description>
                    <link>https://medicalxpress.com/news/2026-05-genome-wide-screen-yields-gene.html</link>
                    <category></category>
                    <pubDate>Mon, 11 May 2026 16:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news697733926</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/genome-wide-screen-yie.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Gene duplication tied to juvenile glaucoma in 20 patients across 10 families</title>
                    <description>A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma. Published today in the journal JAMA Ophthalmology, the study marks another important step toward treating multiple forms of glaucoma with the support of genetic testing. While glaucoma typically affects older adults, many people are unaware it can affect younger people too.</description>
                    <link>https://medicalxpress.com/news/2026-05-gene-duplication-juvenile-glaucoma-patients.html</link>
                    <category></category>
                    <pubDate>Thu, 07 May 2026 13:20:02 EDT</pubDate>
                    <guid isPermaLink="false">news697378081</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/kid-with-glasses-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Certain migraine prevention drugs associated with reduced risk of glaucoma</title>
                    <description>A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published in Neurology. The study compared 36,822 people who took calcitonin gene-related peptide (CGRP) inhibitor drugs to prevent migraine to the same number of people who took other types of migraine prevention drugs. However, the results do not prove that CGRP inhibitor drugs directly cause the reduced risk of glaucoma; they only show an association.</description>
                    <link>https://medicalxpress.com/news/2026-05-migraine-drugs-glaucoma.html</link>
                    <category></category>
                    <pubDate>Wed, 06 May 2026 19:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news697305841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glaucoma.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Low-dose eye drops can manage adult myopia for 24 hours</title>
                    <description>Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor of Optometry Lisa Ostrin and postdoctoral researcher Barsha Lal are reporting that even one drop in the eye of low-dose atropine (0.01%–0.1%) produces clear changes in pupil size and focusing ability that persist for at least 24 hours. Importantly, they also found that the drop shows no short-term structural effects on the eye, with only temporary changes in blood flow inside the retina.</description>
                    <link>https://medicalxpress.com/news/2026-05-dose-eye-adult-myopia-hours.html</link>
                    <category></category>
                    <pubDate>Mon, 04 May 2026 15:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news697123801</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/low-dose-eye-drops-can.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How sugar fuels sight: Glucose metabolism linked to epigenetic and gene expression changes in the retina</title>
                    <description>National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings suggest that metabolic disruptions seen in aging and disease may directly destabilize the gene expression needed to keep photoreceptors healthy, opening new avenues for treating retinal diseases such as age-related macular degeneration (AMD), a leading cause of vision loss. The work is published in PLOS Genetics.</description>
                    <link>https://medicalxpress.com/news/2026-05-sugar-fuels-sight-glucose-metabolism.html</link>
                    <category></category>
                    <pubDate>Mon, 04 May 2026 13:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news697117741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/research-points-to-new.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Seeing keratoconus earlier with light polarization and AI</title>
                    <description>Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams. Yet this is when accurate diagnosis matters most, especially when patients are being evaluated for refractive surgery.</description>
                    <link>https://medicalxpress.com/news/2026-05-keratoconus-earlier-polarization-ai.html</link>
                    <category></category>
                    <pubDate>Mon, 04 May 2026 07:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news697088941</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/seeing-keratoconus-ear.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experiments advance efforts to restore vision with transplanted neurons</title>
                    <description>Researchers at Johns Hopkins Medicine say they have successfully demonstrated that disrupting an eye structure long suspected of blocking the growth and survival of transplanted nerve cells may help restore vision in people with optic nerve damage.</description>
                    <link>https://medicalxpress.com/news/2026-04-advance-efforts-vision-transplanted-neurons.html</link>
                    <category></category>
                    <pubDate>Wed, 29 Apr 2026 14:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news696676981</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/vision.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Swept-source optical coherence tomography angiography may predict diabetic nephropathy</title>
                    <description>Nonperfusion area detected by swept-source optical coherence tomography angiography (OCTA) may predict diabetic nephropathy (DN) severity, according to a study published in the July issue of the American Journal of Ophthalmology.</description>
                    <link>https://medicalxpress.com/news/2026-04-swept-source-optical-coherence-tomography.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Apr 2026 22:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news696597858</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/swept-source-optical-c.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Macaques reveal human-like genetic cause of inherited blindness, offering new disease model</title>
                    <description>An inherited form of blindness directly comparable to a common inherited optic nerve disease in humans has been discovered in rhesus macaques at the California National Primate Research Center at the University of California, Davis. The work, published in Proceedings of the National Academy of Sciences, could lead to a better understanding of autosomal dominant optic atrophy (ADOA), and potentially to new treatments.</description>
                    <link>https://medicalxpress.com/news/2026-04-macaques-reveal-human-genetic-inherited.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Apr 2026 18:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news696610020</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/identifying-genetic-ca.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>America&#039;s fastest-growing sport has an eye injury problem few older players see coming</title>
                    <description>Pickleball-related eye injuries are on the rise in the United States, according to a study published in the journal Eye and led by Houston Methodist. The findings underscore a public health concern tied to one of America&#039;s fastest-growing sports. In addition, the research also revealed that dodgeball and kickball continue to cause significant eye-related trauma, primarily among younger individuals.</description>
                    <link>https://medicalxpress.com/news/2026-04-america-fastest-sport-eye-injury.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Apr 2026 10:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news696071582</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/steep-rise-in-pickleba.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI can use a photo of the eye to estimate retinal age, flag risk for major diseases</title>
                    <description>There may be some truth to the saying &quot;the eyes are the window to the soul.&quot; Age-related changes are reflected in the retina, the light-sensitive tissue at the back of the eye. Recent research shows that a photo of the retina may also reveal potential risks for major diseases like diabetes.</description>
                    <link>https://medicalxpress.com/news/2026-04-ai-photo-eye-retinal-age.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Apr 2026 12:40:09 EDT</pubDate>
                    <guid isPermaLink="false">news695992861</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/ai-can-use-a-photo-of.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>One exam for the whole retina can mean fewer settings, fewer complications and more information</title>
                    <description>The more precisely we want to examine the human retina, the more clearly one of the fundamental limits of physics becomes apparent. In cellular-resolution eye imaging, the same tradeoff has applied for years—tiny structures can be seen with impressive sharpness, but only within a very thin layer of tissue. To view the entire retina, researchers usually have to refocus and acquire several separate scans in a repetitive manner. Now an international team led by Dawid Borycki and Maciej Wojtkowski from ICTER, together with Zhuolin Liu and Daniel X. Hammer from the FDA Center for Devices and Radiological Health (CDRH), has shown that this limitation can be overcome.</description>
                    <link>https://medicalxpress.com/news/2026-04-exam-retina-complications.html</link>
                    <category></category>
                    <pubDate>Mon, 20 Apr 2026 16:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news695917381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/one-exam-for-the-whole.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>&#039;MitoCatch&#039; delivers healthy mitochondria to diseased cells</title>
                    <description>Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) have developed MitoCatch, a system that enables targeted delivery of healthy mitochondria to specific cell types affected by disease. This innovation is a major step toward precision mitochondrial therapy.</description>
                    <link>https://medicalxpress.com/news/2026-04-mitocatch-healthy-mitochondria-diseased-cells.html</link>
                    <category></category>
                    <pubDate>Wed, 15 Apr 2026 11:00:07 EDT</pubDate>
                    <guid isPermaLink="false">news695394961</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/mitocatch-delivers-hea.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Lab-grown retina gives gene change clue to rare childhood eye condition</title>
                    <description>A study using tiny retinas grown in a lab has revealed how subtle changes in a key growth-controlling protein can lead to a condition causing serious eye defects from birth. The findings, published in the journal Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, shed new light on ocular coloboma, a rare congenital eye condition affecting about 1 in 5,000 births and responsible for roughly 10% of childhood blindness. Coloboma arises when a structure in the developing eye, the optic fissure, fails to close properly and often co-occurs with other tissue-fusion problems such as cleft lip and/or palate.</description>
                    <link>https://medicalxpress.com/news/2026-04-lab-grown-retina-gene-clue.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 20:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news695290418</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/lab-grown-retina-gives.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Surprising finding in the eye may explain how we see in low light</title>
                    <description>A new Yale School of Medicine (YSM) study has uncovered surprising new details about how our eyes process what we see. When we look at something, our visual system breaks down different aspects of the scene—such as color, contrast, and motion—and processes those components separately. It&#039;s called parallel visual processing and it&#039;s what allows our brains to work out what we&#039;re seeing so quickly.</description>
                    <link>https://medicalxpress.com/news/2026-04-eye.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 17:20:12 EDT</pubDate>
                    <guid isPermaLink="false">news694946205</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/light-in-eye.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>When should I get LASIK? Age, eligibility, and recovery explained</title>
                    <description>If you&#039;ve been thinking about ditching your glasses or contacts, you might be wondering: Is now a good time for LASIK surgery? Is there a &quot;best age?&quot; Should you wait until your prescription stops changing?</description>
                    <link>https://medicalxpress.com/news/2026-04-lasik-age-eligibility-recovery.html</link>
                    <category></category>
                    <pubDate>Thu, 09 Apr 2026 10:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news694947541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glasses-and-contacts.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
